top of page

Walid Ayoub

MD

Professor of Medicine at Cedars-Sinai Medical Center and UCLA, Associate Medical Director, Liver Transplant Program at Cedars-Sinai Medical Center.

Dr. Ayoub achieved his Medical Degree at Creighton University School of Medicine, Omaha in 1999, before taking up residency at UCLA/West Los Angeles Veteran Administration Hospital. Between 2002–2006, Professor Ayoub conducted fellowships in Hepatology and Gastroenterology at Cedars-Sinai Medical Center and UCLA, respectively. He then became Clinical Assistant Professor of Medicine at Stanford University until 2012, when he assumed his current position at Cedars-Sinai Medical Center.

Dr. Ayoub is board certified in Gastroenterology and Transplant Hepatology. He has been involved in several clinical trials investigating pharmacological therapies for liver impairments, fatty liver disease, cholestatic liver diseases, viral and cholestatic hepatitis. He is currently a primary investigator for clinical trials assessing the efficacy of novel agents in the treatment of fatty liver, primary biliary cholangitis and primary sclerosing cholangitis. He is a member of the PSC CALiD consortium- Clinical Outcomes of Primary Sclerosing Cholangitis in North America. He serves as a primary investigator on NIH/NCI sponsored trial addressing the chemoprevention role of statin on hepatocellular carcinoma.

Dr. Ayoub has been an invited speaker at the Digestive Disease meetings and has moderated sessions at American Association for the Study of Liver Disease discussing liver cancer. He has addressed treatments of viral hepatitis at the American Transplant Congress and has delivered presentation on discussing quality of organs in the solid organ transplant recipient.

Dr. Ayoub served as a member of the Hepatology Associate Committee of the American Association for the Study of Liver Diseases (AASLD). He is also a Fellow at AASLD and a member of the American Gastroenterological Society, American College of Gastroenterology and American Society of Transplantation. Dr. Ayoub has also held responsibilities as Editor of Journal of Pancreatic Disorders & Therapy and a reviewer for a variety of journals such as the American Journal of Transplantation, Liver Transplantation, Journal of Clinical Gastroenterology and Digestive Diseases and Sciences.

Dr. Ayoub’s research has been published in peer-reviewed journals including Clinical Gastroenterology and Hepatology, American Journal of Transplantation, Alimentary Pharmacology & Therapeutics, and Journal of Viral Hepatitis and he has also written numerous reviews, book chapters and abstracts.

Dr. Ayoub’s Specialties: Hepatology, hepatitis B, hepatitis C, hepatitis D, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis, cirrhosis, portal hypertension, end stage liver disease, acute liver failure, liver cancer, liver transplantation, and Fatty Liver disease.

Walid Ayoub
bottom of page